Lidocaine is an amide local anesthetic sold in the U.S. under 17 brand and generic names, for burns, esophageal diseases and mouth diseases. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
From the FDA label for Lidocaine Hydrochloride Preservative Free (application ANDA084625). Other lidocaine products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.
See Full Prescribing Information for recommended dosages and administration information for adult and pediatric patients 2.1 Important Dosage and Administration Information Lidocaine Hydrochloride Injection is not recommended for intrathecal use. Avoid use of Lidocaine Hydrochloride Injection solutions containing antimicrobial preservatives (i.e., multiple-dose vials) for epidural or caudal anesthesia [see Warnings and Precautions (5.3) ]. Discard unused portions of solution not containing preservatives, i.e., those supplied in single-dose vials, following initial use. Visually inspect this product for particulate matter and discoloration prior to administration whenever solution and container permit. Lidocaine Hydrochloride Injection is clear, colorless solution. Do not administer solutions which are discolored or contain particulate matter. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever the solution and container permit. Solutions which are discolored (e.g., pinkish or darker than slightly yellow) or which contain particulate matter or precipitate should not be administered. Mixing or the prior or intercurrent use of any other local anesthetic with Lidocaine Hydrochloride Injection is not recommended because of insufficient data on the clinical use of such mixtures. Administration Precautions…
The following clinically significant adverse reactions have been reported and described in the Warnings and Precautions section of the labeling: Dose-Related Toxicity [see Warnings and Precautions (5.1) ] Methemoglobinemia [see Warnings and Precautions (5.2) ] Chondrolysis with Intra-Articular Infusion [see Warnings and Precautions (5.4) ] Severe, Persistent Hypertension, Cerebrovascular Accidents, and Bradycardia Due to Drug Interactions [see Warnings and Precautions (5.5) ] Allergic-Type Reactions [see Warnings and Precautions (5.6) ] Systemic Toxicities with Unintended Intravascular or Intrathecal Injection [see Warnings and Precautions (5.7) ] Respiratory Arrest Following Retrobulbar Block [see Warnings and Precautions (5.14) ] The following adverse reactions from voluntary reports or clinical studies have been reported with lidocaine or lidocaine and epinephrine. Because many of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Adverse reactions to Lidocaine Hydrochloride Injection are characteristic of those associated with other amide type local anesthetic. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, unintentional intravascular injection, or slow…
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Typical price | |
|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Topical | Generic | $0 | View → | |
| 2 | 70/100 | Prescription | Injectable | Generic |
A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.
From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.
Lidocaine HCl Injection
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Eugia US LLC · May 18, 2026
Lidocaine HCl Injection USP
Lack of Assurance of Sterility
Spectra Medical Devices, Llc · May 12, 2026
Lidocaine Wound Gel (Benzalkonium Chloride
Failed PH Specifications
Water-Jel Technologies, LLC · Apr 7, 2026
Lidocaine HCl Injection
Lack of Assurance of Sterility
Huons Co., Ltd. · Apr 2, 2026
Lidocaine HCl injection
Lack of Assurance of Sterility
Huons Co., Ltd. · Apr 2, 2026
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Lidocaine Hydrochloride Injection is contraindicated in patients with a known hypersensitivity to lidocaine or to any local anesthetics of the amide type or to other components of Lidocaine Hydrochloride Injection. Known hypersensitivity to any local anesthetic agent of the amide-type or to other components of Lidocaine Hydrochloride Injection.
Local Anesthetics: The toxic effects of local anesthetics are additive. Monitor for neurologic and cardiovascular effects when additional local anesthetics are administered (7.1) Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: Administration of Lidocaine Hydrochloride Injection to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension. Concurrent use of these agents should generally be avoided ( 5.5, 7.2 ) Ergot-type Oxytocic drugs: Concurrent administration of Lidocaine Hydrochloride Injection and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents ( 5.5, 7.3 ) Nonselective Beta-Adrenergic Antagonists: Administration of Lidocaine Hydrochloride Injection in patients receiving nonselective beta-adrenergic antagonist may cause severe hypertension and bradycardia. Concurrent use of these agents should generally be avoided. ( 5.5 , 7.4) Drugs Associated with Methemoglobinemia: Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants and other drugs ( 7.5 ). Potent Inhalation Anesthetics: Serious dose-related cardiac arrhythmias may occur if preparations containing epinephrine are used in patients during or following the…
| $0 |
| View → |
| 3 | 70/100 | Prescription | Injectable | Generic | $0 | View → |
| 4 | 64/100 | Prescription | Film | Generic | $0 | View → |
| 5 | 62/100 | Prescription | Injectable | Generic | $0 | View → |
| 6 | 62/100 | Prescription | Injectable | Generic | $0 | View → |
| 7 | 62/100 | Prescription | Injectable | Generic | $0 | View → |
| 8 | 62/100 | Prescription | Solution | Generic | $0 | View → |
| 9 | 54/100 | Prescription | Injectable | Generic | $0 | View → |
| 10 | 54/100 | Prescription | Injectable | Generic | $0 | View → |